Assembly Biosciences develops antiviral medicines for serious viral diseases, including genital herpes and hepatitis. It last closed at $22.50 on Nov 17, up 5.68% on the day.
Only 1 firm rated ASMB in the past 90 days, not enough for a consensus
Average 12-month target
$48.00
▲ 113.3% upside
Based on 1 analyst who set a price target on ASMB in the past 90 days. The average target is $48.00, with a high of $48.00 and a low of $48.00, compared with the last close of $22.50.
Low $48.00Avg $48.00High $48.00
Blue marker: last close $22.50
Highest target$48.00
Average target$48.00
Lowest target$48.00
Latest rating changes
UBSTarget lowered
Nov 3Buy$52 → $48
UBSInitiated
Sep 1Buy$52
HC Wainwright & Co.Reiterated
Aug 18Buy$50
MizuhoMaintained
Jun 15Buy$45
Date
Firm
Action
Rating
Price target
Nov 3
UBS
Target lowered
Buy
$52 → $48
Sep 1
UBS
Initiated
Buy
$52
Aug 18
HC Wainwright & Co.
Reiterated
Buy
$50
Jun 15
Mizuho
Maintained
Buy
$45
Loading…
Technical Analysis
ASMB · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend
The stock sits between its 20 and 50 day averages. It is 19% below its 200 day average, so the longer trend is down. Momentum is strong (RSI 56). The nearest support is the Pivot at $22.12, and the nearest resistance the swing high (Nov 11) at $22.69.
Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityNormal, 5.6%/day
Key levels
$39.7152 week high+76.5%
$26.81200 day average+19.2%
$26.02100 day average+15.6%
$22.98Pivot R1+2.1%
$22.6950 day average+0.8%
$22.69Swing high (Nov 11)+0.8%
$22.50Last close
$22.12Pivot−1.7%
$21.80Swing low (Jun 11)−3.1%
$21.64Pivot S1−3.8%
$20.6220 day average−8.4%
$19.2052 week low−14.7%
Indicators
RSI (14)
55.53
Middle of its range
Neutral
MACD
-0.28
Above its signal line
Bullish
Stochastic
69.8
Middle of its range
Neutral
ADX (14)
23.0
Weak trend
Williams %R
-5.4
Oversold below −80, overbought above −20
Overbought
CCI (20)
176.2
Oversold below −100, overbought above 100
Overbought
Rate of change
+12.9%
Change over 10 sessions
Bullish
ATR (14)
$1.27
Typical daily range, 5.6% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 14.4%/day
Key levels
$39.7152 week high+76.5%
$26.81200 day average+19.2%
$26.02100 day average+15.6%
$22.98Pivot R1+2.1%
$22.6950 day average+0.8%
$22.69Swing high (Nov 11)+0.8%
$22.50Last close
$22.12Pivot−1.7%
$21.80Swing low (Jun 11)−3.1%
$21.64Pivot S1−3.8%
$20.6220 day average−8.4%
$19.2052 week low−14.7%
Indicators
RSI (14)
43.54
Middle of its range
Neutral
MACD
-1.94
Below its signal line
Bearish
Stochastic
12.1
Near the bottom of its range
Oversold
ADX (14)
17.5
No clear trend
Williams %R
-81.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-66.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−24.5%
Change over 10 sessions
Bearish
ATR (14)
$3.23
Typical daily range, 14.4% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for ASMB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ASMB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ASMB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ASMB has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASMB is in one of them and how their past ASMB trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Assembly Biosciences
Assembly Biosciences is a biotechnology company based in South San Francisco, California, that develops antiviral medicines for people with serious viral diseases. Its experimental treatments target genital herpes, hepatitis delta, hepatitis B and herpesviruses that can affect transplant patients. Gilead Sciences has licensed its genital herpes program, and the company is seeking partners for its hepatitis B candidate. Its other programs remain in clinical testing or early research.